Kota: Public health authorities have ordered an immediate halt to the use and distribution of specific batches of three intravenous (IV) fluids across the state after three patients at the Sultanpur Community Health Centre (CHC) in Kota experienced adverse reactions following administration of the drips. This incident comes less than two weeks after five women died and several others were left in critical condition at Kota's New Medical College and J K Lon hospitals due to suspected hospital-acquired infections.
Details of the Incident
Dr. Shyam Bihari Malav, in-charge of Sultanpur CHC, reported that three patients—Chintu Meghwal (17), Dinesh Gochar (45), and Shabana (34)—developed symptoms such as severe shivering, anxiety, and dizziness shortly after being administered IV fluids on Sunday. Gochar, who was being treated for diarrhoea, experienced severe chills immediately after the IV fluid was given and had to be referred to the district headquarters when his condition did not improve. He is currently under treatment at a private hospital, while the other two patients are stable at the CHC.
Action Taken
Dr. Malav stated, 'The use of notified batches of three IV fluids has been stopped immediately. We have also written to the drug department for their testing, and samples will be forwarded to Jaipur for analysis.' The three flagged IV fluids are RL Compound Sodium Lactate Injection, Sodium Chloride and Dextrose 500 ML, and NS Sodium Chloride (0.9%) 500 ML.
Dr. Jagdish Soni, joint director (medical and health), Kota, confirmed that the health department has ordered an immediate, statewide hold on the use and distribution of particular batches of these three IV fluids. He said he has written to state health authorities after receiving a report on the incident from Sultanpur CHC. Dr. Soni added that no reports of adverse reactions from IV fluids have been received from any other health facility in the Kota division.
